Among all SLE patients in our study, both EBV VCA-IgG and EBNA1-IgG antibodies could not be compared with the controls due to the high percentage of antibodies present in all adult patients, but we still found a significantly higher (P < 0.001) prevalence of serum VCA-IgA among all SLE patients versus the age matched controls. The gene discussed is CD79A; the disease is systemic lupus erythematosus.